Skip to Main Content

Economic Evidence

Mepilex® Border is the proven 5-layer foam prevention dressing  

Mepilex Border Sacrum is the only 5-layer silicone foam dressing with real-world health economic evidence in pressure ulcer prevention showing a $200,000-600,000 cost savings with $77 reduction in per patient treatment costs in a cohort of 1.03m patients.  

In a recent 6-year observational study by William Padula, PhD, Johns Hopkins Bloomberg School of Public Health, published in the JWOCN the following was observed:

1. Stage 3, 4 or Unstageable hospital-acquired pressure injury outcomes were examined in 38 academic medical centers and a cohort of 1.03 million high- risk patients between 2010-2015.

2. The average AMC saw a reduction of 1 reportable pressure injury per quarter, saving 4 patients per year from serious pressure injury.  

Economic evidence

In a recent randomized controlled trial by Kalowes et al, Mepilex® Border Sacrum was associated with an 88% reduction in risk of  of pressure ulcers. For an ICU department with 1,000 admissions, this pressure ulcer reduction could translate to significant cost savings.

The authors state:

"Cost savings for our health system have been significant ... Organizational estimates demonstrate that a savings of more than $1 million has been amortized in the past two years, after dressing purchase. This estimate is most likely conservative, given that the Society of Actuaries estimates the cost of treating a pressure ulcer ranges from $2,000 to $20,000 per ulcer, depending on severity. This cost savings estimate related to prevention is also consistent with other cost analysis studies of pressure ulcers."   

View our other economic studies
Economic studies

Share this page on social media

Contact us
Select market

Select your market